In June 2020, Chanelle Pharma received the Food and Drugs Administration (FDA) approval to manufacture Spot on in the US market. Spot On is a topical treatment used to protect cats and dogs against parasites.
In September 2020, Boehringer Ingelheim International Gmbh acquired an equity stake in New Ruipeng Group (NRP Group), a Chinese company involved in veterinary care, e-commerce, and other services.
In April 2020, Ceva Sante Animale launched the cattle pain campaign to raises awareness about the importance of pain reliefs in lame cattle.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients